Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Airway MedixWAR:AWM +1.12%17 EV-to-EBIT is 13.11 as of Aug. 15, 2026. GuruFocus rates WAR:AWM with a GF Score™ of 17/100. The stock has 9 warning signs investors should review. Among 473 Medical Devices & Instruments companies, Airway Medix ranks better than 70.19% on this metric.
The historical rank and industry rank for Airway Medix's EV-to-EBIT or its related term are showing as below:
WAR:AWM'
s EV-to-EBIT Range Over the Past 10 Years
Min: -275.1 Med: -0.96 Max: 1027.44
Current: 13.11
During the past 12 years, the highest EV-to-EBIT of Airway Medix was 1027.44. The lowest was -275.10. And the median was -0.96.
WAR:AWM's EV-to-EBIT is ranked better than 70.19% of 473
companies
in the Medical Devices & Instruments industry
Industry Median: 19.17
vs WAR:AWM: 13.11
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Airway Medix's Enterprise Value for the quarter that ended in Mar. 2026 was zł48.07 Mil.
Airway Medix's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł3.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Airway Medix EV-to-EBIT Related Terms
Airway Medix EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Airway Medix's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Airway Medix's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Airway Medix EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Airway Medix's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Airway Medix's EV-to-EBIT falls into.
Airway Medix's current Enterprise Value is zł39.45 Mil.
Airway Medix's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł3.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Airway Medix (WAR:AWM) has a EV-to-EBIT of 13.11 as of Aug. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Airway Medix and its competitors. According to the industry distribution chart, Airway Medix ranks #141 out of 473 companies in the Medical Devices & Instruments industry, placing it in the top 29.8%.
Is Airway Medix's EV-to-EBIT too high?
Airway Medix's current EV-to-EBIT is 13.11. The Medical Devices & Instruments industry median EV-to-EBIT is 19.17. Airway Medix's value of 13.11 is 31.6% below this industry median. Based on the distribution chart, Airway Medix ranks #141 out of 473 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Airway Medix has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Airway Medix's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Airway Medix ranks #141 out of 473 companies for EV-to-EBIT. This puts Airway Medix in the upper half of its industry. The industry median EV-to-EBIT is 19.17. Airway Medix's value of 13.11 is 31.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.17, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Airway Medix's current EV-to-EBIT of 13.11 is 31.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Airway Medix and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Airway Medix's current EV-to-EBIT is 13.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Airway Medix stock overvalued right now?
Airway Medix (WAR:AWM) has a current EV-to-EBIT of 13.11. The current EV-to-EBIT is 13.11 and 31.6% below the Medical Devices & Instruments industry median of 19.17. Airway Medix's overall GF Score™ is 17/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Airway Medix (WAR:AWM), the current EV-to-EBIT is 13.11 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Airway Medix SA focuses on research, development, and commercialization of devices for single use in mechanically ventilated patients at Intensive Care Units as well as in patients with life-threatening and anaesthesiologic wards. The company's products include the Closed Suction System, the Oral Care System, and the Cuff Pressure Regulator.
17GF Score
Get the complete analysis for WAR:AWM
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:AWM has been successfully added to your 
